Form 4: Amneal Pharmaceuticals Director Exercises Stock Options
SEC Form 4 Filing
Director Emily Peterson Alva exercised stock options for 76,453 shares of Amneal Pharmaceuticals Class A Common Stock on May 10, 2024.
Summary
- On May 10, 2024, Emily Peterson Alva, a director of Amneal Pharmaceuticals, exercised restricted stock units, acquiring 76,453 shares of Class A Common Stock.
- This transaction was reported in a Form 4 filing with the SEC.
- Following the transaction, Alva directly owns 250,771 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a standard transaction related to executive compensation.
Industry Context
This is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Key Dates
| Date | Description |
|---|---|
| 05/09/2023 | Reporting person was granted 76,453 restricted stock units vesting on May 10, 2024. |
| 05/10/2024 | Director exercised restricted stock units. |
| 05/14/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.